Compounds > fingolimod hydrochloride
Page last updated: 2024-09-02

fingolimod hydrochloride and Meningitis, Cryptococcal

fingolimod hydrochloride has been researched along with Meningitis, Cryptococcal in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (40.00)24.3611
2020's3 (60.00)2.80

Authors

AuthorsStudies
Berger, JR; Cree, BAC; Del Poeta, M; Greenberg, B; Hach, T; Hemmer, B; Kilaru, A; Komatireddy, S; Mishra, J; Moore, A; Sullivan, R; Ward, BJ1
Darazam, IA; Gharehbagh, FJ; Hatami, F; Lotfollahi, L; Moradi, O; Nourinia, R; Rabiei, MM; Roozbeh, M; Shojaei, M1
Alkabie, S; Cuascut, FX; Hutton, GJ1
Bennett, I; Jithoo, R; Pham, C1
Goldman, MD; Jones, DE; Ward, MD1

Other Studies

5 other study(ies) available for fingolimod hydrochloride and Meningitis, Cryptococcal

ArticleYear
Cryptococcal Meningitis Reported With Fingolimod Treatment: Case Series.
    Neurology(R) neuroimmunology & neuroinflammation, 2022, Volume: 9, Issue:3

    Topics: Databases, Factual; Female; Fingolimod Hydrochloride; Humans; Incidence; Male; Meningitis, Cryptococcal; Middle Aged; United States

2022
A Case of Fingolimod-associated Cryptococcal Meningitis.
    Current HIV research, 2022, Volume: 20, Issue:4

    Topics: Adult; Antifungal Agents; Cryptococcus neoformans; Female; Fingolimod Hydrochloride; HIV Infections; Humans; Meningitis, Cryptococcal

2022
Fingolimod-related cryptococcal meningoencephalitis and immune reconstitution inflammatory syndrome in a patient with multiple sclerosis.
    Multiple sclerosis and related disorders, 2021, Volume: 53

    Topics: Fingolimod Hydrochloride; Humans; Immune Reconstitution Inflammatory Syndrome; Immunosuppressive Agents; Meningitis, Cryptococcal; Meningoencephalitis; Multiple Sclerosis

2021
Cryptococcal meningitis causing obstructive hydrocephalus in a patient on fingolimod.
    BMJ case reports, 2017, Jul-06, Volume: 2017

    Topics: Diagnosis, Differential; Female; Fingolimod Hydrochloride; Humans; Hydrocephalus; Immunosuppressive Agents; Meningitis, Cryptococcal; Middle Aged; Multiple Sclerosis; Treatment Outcome; Ventriculoperitoneal Shunt

2017
Cryptococcal meningitis after fingolimod discontinuation in a patient with multiple sclerosis.
    Multiple sclerosis and related disorders, 2016, Volume: 9

    Topics: Aged; Fatal Outcome; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Meningitis, Cryptococcal; Mesencephalon; Multiple Sclerosis, Relapsing-Remitting

2016